Solid cancers are a leading cause of death worldwide, primarily due to the failure of effective
clinical detection and treatment of metastatic disease in distant sites. There is growing …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

Circulating tumour cells (CTCs) have been considered for a long time in reflecting the
aggressiveness of tumours. As a result, many attempts have been made to develop assays …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Eight million people die of cancer each year and 90% of deaths are caused by systemic
disease. Circulating tumor cells (CTCs) contribute to the formation of metastases and thus …

Circulating tumor cells (CTCs) can be separated and characterized from normal
hematopoietic cellular constituents by a variety of methods. Different strategies have …

Although circulating tumor cells (CTCs) were first observed over a century ago, lack of
sensitive methodology precluded detailed study of these cells until recently. However …

The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Circulating tumor cells (CTCs) may be detected in the blood of patients with epithelial tumors
using different analytical approaches. The relative number of CTCs is low and they include a …

Circulating tumor cells (CTCs) have long been assumed to be the substrate of cancer
metastasis. However, only in recent years have we begun to leverage the potential of CTCs …